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Abstract    
   
Plants used in traditional medicine in Bukoba Rural district in Tanzania were evaluated for their in 
vitro antimicrobial activities. Plant materials from eight plant species (Harungana madagascariensis (Lam) 
Poir., Jatropha curcas L., Lantana trifolia L., Plectranthus barbatus Andr., Pseudospondias microcarpa 
Engl., Psorospermum febrifugum Spach, Teclea nobilis Del. and Vernonia adoensis [Warp.] SL) were 
collected based on ethnomedical information provided by traditional herbal practitioners. Results of the 
study indicate that extracts from the eight plant species were active against at least one or more of the test 
organisms (Bacillus subtilis, Staphylococcus aureus [gram positive], Escherichia coli, Pseudomonas 
aeruginosa [gram negative] and Candida albicans [Yeast]). A profile of secondary metabolites (alkaloids, 
terpenoids, triterpenes, phenolics, tannins, flavonoids, anthraquinones, flavonols/flavones and /or 
chalcones, sterols and saponins) was obtained  for three plant species (Jatropha curcas L., Plectranthus 
barbatus Andr., and Pseudospondias microcarpa Engl.). The paper discusses the probable therapeutic basis 
of these traditional plants based on their secondary metabolite profiles and for the first time draws research 
attention to Bukoba Rural district as a source for plants with potential pharmaceutical applications.  
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Introduction 
 
Traditional medicine continues to provide health coverage for over 80% of the world population, 
especially in the developing world (WHO, 2002). In Africa, traditional healers have for centuries been the 
main providers of primary health care (Scheinman, 2002; Kala et al., 2004). In Tanzania, the use of 
traditional medicine for the treatment of various diseases has been practiced for generations and a large 
number of the population in the country use traditional medicines for their day to day healthcare needs 
(Moshi et  al., 2006; Hamza et al., - In press). 
Many efforts have been made to discover new antimicrobial compounds from various kinds of 
sources such as micro organisms, animals and plants (Janovka et al., 2003). However, the increasing 
prevalence of multidrug resistant bacteria and fungi, the recent appearance of strains with reduced 
susceptibility to antibiotics, the side effects associated with antibiotics, the high costs of antimicrobial 
drugs and the re-emergence of diseases like tuberculosis are the key factors that obstruct resonant 
management of bacterial and fungal infections in many developing countries including Tanzania (Janovka 
et al., 2003; Runyoro et al., 2006; Hamza et al., -In Press). The increased prevalence of HIV/AIDS virus 
has also in the recent past augmented the magnitude of many bacterial and fungal opportunistic infections 
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with frequent episodes resulting from the immune suppression of the affected persons, (Bii, 2001; Runyoro 
et al., 2006).  Consequently, this has raised the spectre of untreatable microbial infections and adds the 
urgency to the search for new infection-fighting strategies. (Janovka et al., 2003). 
Plants that are traditionally used in the treatment of bacterial and fungal infections or related 
ailments could be a good source for new, safe and biodegradable antimicrobial drugs (Hamza et al., – In 
press), and could offer potential lead towards development of novel compounds that are active against 
pathogenic microbes (Runyoro et al., 2006). Thus, chemical studies of Tanzanian medicinal plants could 
provide a valuable material base for the discovery and development of new drugs of natural origin (Moshi 
et al., 2006). 
The present study was carried out in Bukoba Rural district which is faced by severe inadequacy of 
health facilities, with a population-doctor ratio of 1:95,000, the lowest of all the six districts forming 
Kagera region in the Northern part of Tanzania (TUROT, 2003; TACAIDS et al., 2005). Majority of the 
population in the district are poor and cannot afford the usually expensive conventional drugs which are 
hardly available in many of the local health centers. Besides, many people are forced to walk for long 
distances to reach a health facility (TUROT, 2003). This has forced the local population to turn to 
traditional plant remedies which are readily available, more affordable, less toxic, and have a wide 
acceptance around the world (WHO, 2002).   Therefore, the current study forms a strong basis for 
identifying plants with potential pharmaceutical applications not only in the study area, but also in the 
world. 
 
Material and Methods 
Criteria for selection and collection of plant materials for analysis  
 
Different parts of eight plant species were collected from Bukoba Rural district and prepared for 
bioactivity and phytochemical screening. The plant species collected for analysis were Harungana 
madagascariensis (Lam) Poir., Jatropha curcas L., Lantana trifolia L., Plectranthus barbatus Andr., 
Pseudospondias microcarpa (A. Rich) Engl., Psorospermum febrifugum Spach, Teclea nobilis Del. and 
Vernonia adoensis (Warp.) SL. (Table 1).  With a Prior Informed Consent (PIC), ethnomedical information 
about the eight plant species was sourced from three authentic herbal practitioners (One man and two 
women), who were identified with the help of local administration officers and interviewed using an open-
ended semi-structured questionnaire according to Martin (1995). Voucher specimens were collected and 
identified by Mr. Frank Mbago and Mr. Suleiman Haji of the University of Dar es Salaam Botany 
Department Herbarium, where they were coded and deposited (Table1).  Collection of the plant materials 
from the eight species for in vitro bioactivity assays was pegged on informant consensus on their 
ethnomedical uses enumerated in Table 1. Only the parts of the plants used by the herbal practitioners were 
collected for analysis. Leaves were collected for seven of the eight plant species while stem/bark was 
collected for only one plant species. No roots were collected for analysis (Tables 1, 2 and 3).  
 
Preparation of the plant extracts 
 
Fresh plant materials were chopped into smaller pieces before drying and then air dried under 
shade for a period of ten days. The dried plant materials were then pulverized using a NATIONAL 
SUPER® mixer grinder [MX-119] (Emerging planet India Ltd., Coimbatore 641011, India). About 300 g of 
each of the pulverized material was extracted using petroleum ether, dichloromethane and water in that 
order as successfully done in other studies (Janovka et al., 2003; Moshi et al., 2006).  These crude extracts 
were concentrated in vacuo using a rotary evaporator (HEIDOLPH®, Essex Scientific laboratory supplies 
Ltd. Crucible house, Endway, Hadleigh, Benfleet, essex, SS7 2AN) with the bath temperature maintained 
at 400C to prevent thermal decomposition of labile compounds.  The aqueous extracts were obtained by 
using either cold percolation or hot water to mimic the mode of extraction by the herbal practitioners.  The 
organic solvent extracts were dissolved in DMSO while the aqueous extracts were dissolved in water at 
varying concentrations as done in recently reported procedure (Motsei et al., 2003). 
 
Test microorganisms  
 
Five test microorganisms were used in antimicrobial sensitivity tests. They were the gram positive 
bacteria Staphylococcus aureus (ATCC 25923) and Bacillus subtilis (DSM 347) and gram negative bacteria 
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Escherichia coli (DSM 1103) and Pseudomonas aeruginosa (DSM 1117) and the yeast Candida albicans 
(ATCC 90028). These were obtained from the Department of Molecular Biology and Biotechnology 
(MBB), University of Dar es Salaam.  
 
Preparation of the inoculum 
 
Nutrient Broth (NB), (OXOID®, Unipath Ltd. Basingstoke, England) and Malt Extract Broth 
(MEB), (PRONADISA®, Conda Ltd., Madrid, Spain) were used to prepare broth cultures of bacteria and 
yeast test organisms respectively. The broth media were prepared according to the manufacturers’ 
instructions. The autoclaved media was asceptically transferred to sterile capped test tubes of about 6ml 
each. Pure isolates of subcultured bacteria and yeast colonies were asceptically transferred to the respective 
broth media. The approximate cell concentration in the broth was 105 CFU/ml. These were incubated in 
DEPEX MEMMERT® incubator (Bellevue WA 98005, US) for an overnight at 370C and for 48 hours at 
300C for bacteria and Candida respectively.  
 
Antimicrobial activity tests 
 
Antimicrobial activity of the crude extracts was determined by Agar well and Disc diffusion assay 
methods as previously described by Rojas et al. (2006) and Moshi et al. (2006). 
 
Agar well method 
 
Nutrient Agar (LAB MTM, Lancashire, UK) and Malt Extract Agar (PRONADISA®, Conda Ltd. 
Madrid, Spain) were prepared for bacteria and Candida respectively according to the manufacturers’ 
instructions. Immediately after autoclaving, the media was allowed to cool in a 45 to 500C water bath. The 
freshly prepared and cooled media was poured into glass, flat-bottomed petri dishes (90mm in diameter) 
placed on a level, horizontal surface (FASTER® Laminar flow, Cornaredo via Merendi, 22 20010, Italy) to 
give a uniform depth of approximately 4 mm.  The agar media was allowed to cool and solidify at room 
temperature and the plates were incubated at 350C for 18-20 hours before use to ensure sterility.  About 
0.2ml of the test inoculum was evenly spread on the surface of the solidified agar media using a sterile 
grigalsky spatula. Four equidistant wells of 5mm in diameter and 4mm in depth were then made on the agar 
using a sterile cork borer. Two more wells for positive and negative controls were made at the middle of 
the agar. About 25 µl of the plant extracts and controls were filled into the wells (Rojas et al., 2006). 
Concentrations for the crude extracts ranged from 25-200mg/ml. The positive controls were Ampicillin 
(SIGMA®, Sigma chemical Co., st. Louis, USA.), (0.5mg/ml) for gram positive bacteria, Gentamicin 
(IVEE Aqua EPZ Ltd. Nairobi, Kenya), (0.5mg/ml) for gram negative bacteria and Fluconazole (ZOCON®, 
FDC Ltd. India), (1mg/ml) for Candida. The negative controls were DMSO for organic solvent extracts 
and distilled water for aqueous extracts. The wells were then labeled to correspond with the code numbers 
of the test crude extracts and controls.  The treated plates were stored in a refrigerator (DAEWOO®, 
Daewoo Electronics, Europe GmbH, Germany) at 4 0C for atleast six hours to allow diffusion of the 
extracts into the agar while arresting the growth of the test microbes. The plates were then incubated for 24 
hours at 37 0 C for bacteria and for 48 hours at 300C for Candida. The test was carried out in duplicates. 
Antimicrobial activity was determined by measuring the diameters of zones of inhibition in mm. The 
means and standard deviations (±SD) of the diameters of  zones of growth inhibitions for the treatments are 
shown in Table 2.  
 
Disc diffusion method 
 
Preparation of the media and inoculation of the test microbes were performed as described in the 
agar well method. However, instead of punching out wells on the agar, sterile 5 mm-Whatman No. 1 filter 
paper discs (WHATMAN®, Springfield Mill, Maidstone, Kent, England) were used in the disc diffusion 
method (Moshi et al., 2006). The discs were soaked into the dissolved crude extracts for a minimum of two 
hours. Blank discs were impregnated with Ampicillin (10µg/disc) for gram positive bacteria, Gentamicin 
(15µg/disc) for gram negative bacteria and Fluconazole (0.4mg/disc) for Candida and used as positive 
controls. Negative control discs were soaked in DMSO and distilled water for organic solvent and water 
extracts respectively. By use of a sterile forcep, four seeded discs of the plant extracts were placed 
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equidistantly onto each of the inoculated plates. Two extra discs for positive and negative controls were 
placed at the middle of plate. The treated plates were stored in a refregerator (DAEWOO®, Daewoo 
Electronics, Europe GmbH, Germany) at 40C for atleast six hours then transferred to DEPEX MEMMERT® 
incubator (Bellevue WA 98005, US) for 24 hours at 370 C for bacteria and for 48 hours at 300C for 
Candida. The test was carried out in duplicates. Antimicrobial activities were determined by measuring the 
diameters of zones of inhibition in mm. The means and standard deviations (±SD) of the diameters of  
zones of growth inhibitions for the treatments are shown in Table 3.  
 
Phytochemical screening       
 
Screening for secondary metabolites was done for three plants, Jatropha curcas, Plectranthus 
barbatus and Pseudospondias microcarpa whose information on their bioactivity and phytochemistry is 
scanty with regard to their medicinal uses.  Chromatograms were developed on commercial Thin Layer 
Chromatography (TLC) plates using different solvent systems of varying polarities (Houghton and Raman, 
1998; Kinge, 2002; Orech et al., 2005, Edeoga et al., 2005). The chromatograms were observed under 
normal light and UV (254nm, 365nm) before being sprayed with the respective test reagents. Secondary 
metabolites were identified by color establishment using standard spray reagents on the TLC 
Chromatograms as exemplified in figures 2, 3 and 4. The secondary metabolites tested in all the extracts of 
the three plant species were alkaloids, terpenoids, triterpenes, phenolics, tannins, flavonoids, 
anthraquinones, flavonols/flavones and/or chalcones, sterols and saponins. 
To test for alkaloids, chromatograms were sprayed with dragedorff’s reagent and over sprayed 
with aqueous iron (III) chloride. Presence of terpenoids was detected by spraying the chromatograms with 
anisaldehyde and then heating them with a hot air stream from a heating gun (BLACK & DECKER®, 
Black & Decker, Hunt valley, MD 21031, USA). Triterpenes were detected by treating the chromatograms 
with 10% ammonium hydroxide. Phenolic compounds were detected by spraying the plates with 5% 
aqueous iron (III) chloride, then heating them with a hot air stream. Test for presence of flavonoids was 
done by passing the chromatograms on Ammonium hydroxide vapour. Anthraquinones were tested by 
spraying the chromatograms with 10% ammonium hydroxide. Presence of flavonols, flavones and/or 
chalcones was detected by treating the chromatograms with aluminium chloride followed by heating with 
hot air stream from the heating gun. Detection of tannins was done by treating the chromatograms with 
ferric chloride. Sterols were detected by treating chromatograms with 50% acetic anhydride in sulphuric 
acid followed by heating from a hot air stream. Presence of saponins was tested by shaking about 2ml of 
the plant extracts in distilled water.  
 
Results  
 
 All plant species exhibited activity against at least one or more of the microorganisms tested 
(Tables 2 and 3). Amongst the eight plants studied, J. curcas and P. barbatus had the broadest range of 
activity inhibiting the growth of the gram positive, gram negative and the yeast fungus tested. L. trifolia 
had the least range of antimicrobial activity inhibiting the growth of only one of the five microbes tested. E. 
coli was the most susceptible of all the microbes tested followed by B. subtilis. The least susceptible 
microbes were P. aeruginosa and C. albicans.  Generally, bacteria were more susceptible to the plant 
extracts than the yeast Candida, with Activity Index (AI) ranging between 0.22-2.96 and 0.23-0.32 for 
bacteria and Candida respectively. Moreover, activity against C. albicans was observed only in the disc 
diffusion assays but none in the agar well assays. 
 The highest activity was observed in the crude extracts of V. adoensis against E. coli with an 
Activity index (AI) of 1.76 (Table 3). The lowest activity was observed in the crude extracts of P. 
microcarpa with an Activity index of 0.22 (Table 3).  However, the highest Activity index was realized in 
the J. curcas extracts at 2.96 against S. aureus (Table 3). The Activity Index (AI) is an expression of the 
degree of potency of the plant extract in relation to the standard drug (Moshi et al. 2006). Based on the 
Activity index, water extracts portrayed the highest potency of the herbal drugs screened compared to 
Petroleum ether or Dichloromethane extracts.  There were 37 treatments which showed activity against the 
test organisms in the disc diffusion assays as opposed to 24 in the agar well assays (Tables 2 and 3).  
In some cases, the three extracts of the same plant (petroleum ether, dichloromethane and water) had 
antimicrobial activity against the same microorganism. For instance, the three extracts of H. 
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madascariensis were active against B. subtilis, the three extracts of P. febrifugum were active against E. 
coli while those of P. barbatus were active against C. albicans.  Different kinds of secondary metabolites 
were detected in all the plant extracts tested (Table 5). Appearance of colour establishments shown in table 
4 was positive indication of the secondary metabolites tested. P. barbatus had the highest number of 
secondary metabolites, with eight out the ten metabolites screened. The plant with the least number of 
secondary metabolites was P. microcarpa with only three of the ten metabolites screened. Phenolics, 
tannins and sterols were present in all the extracts, while alkaloids and saponins were absent in all the 
extracts screened.   
 
Table 1: Traditional uses of the plants recorded in the field.  
 
Plant name Local 
name 
(Kihaya) 
Family Disease 
treated 
Part 
used 
 
Preparation and 
administration 
Collection 
No. 
Harungana 
madagascariensis 
(Lam) Poir.  
Omujumbo Clusiaceae Chronic 
diarrhea, 
malaria, 
jaundice 
Leaves Boiled and 
decoction drunk 
one cup x 3/day 
DK006/06 
Jatropha curcas L. Ekiyo Euphorbiaceae 
 
Body sores, 
skin 
infections 
Leaves Leaves soaked in 
water, crushed and 
infusion bathed 
with. 
DK011/06 
Lantana trifolia L. Mushikira Verbenaceae Chronic 
cough 
Leaves Boiled and 
decoction drunk 
DK009/06 
Plectranthus 
barbatus Andr.  
Kasindano Lamiaceae Oral thrush, 
skin rashes, 
ring worms, 
Diarrhoea 
Leaves Soaked in water 
and infusion bathed 
with. 
DK010/06 
Pseudospondias 
microcarpa (A. 
Rich) Engl. 
Omuziru Anacardiaceae Chronic 
cough 
Leaves Boiled and 
decoction drunk 
DK005/06 
Psorospermum 
febrifugum Spach 
Ekiana Clusiaceae Skin 
infections 
(Body sores, 
skin rushes-
Herpes 
zoster) 
Bark Boiled and 
decoction drunk 
one cup x3/day. 
Also decoction 
bathed with. 
DK003/06 
Teclea nobilis Del. Omuzo Rutaceae Weight loss, 
Chronic 
cough 
Leaves Boiled and 
decoction drunk 
one cup x 3/day 
DK005/06 
Vernonia adoensis 
(Warp.) SL. 
Nyakibasi Asteraceae TB Leaves Boiled and 
decoction drunk  
DK008/06 
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Discussion     
 The nominal susceptibility of C. albicans to the plant extracts could be associated with the 
presence of supramolecular complexes of its cell wall including chitin, which may be difficult to digest, 
thus imposing resistance to prospective drugs (Marcilla et al., 1991). In the cases where the three kinds 
of extracts of the same plant depicted activity against the same microorganism, would possibly mean that 
the compound responsible for the antimicrobial activity was present in each extract at a different 
concentration as similarly observed by Rojas et al. (2006).An antimicrobial assay on the root extracts of J. 
curcas by Atindehou et al. (2002) reported a negative activity against C. albicans. The anti Candida 
activity of the leaf extracts recorded in the present study (Table 3) may be an indication that the active 
principles against the fungus are present in the leaves of the plant. It is however important that further 
studies on toxicity potential on leaf extracts of J. curcas are carried out as the oil from the seeds of the plant 
have been reported to be rich in toxalbumins which are poisonous proteins and usually irritant in nature 
(Kokwaro, 1993).  
An antimicrobial flavonoid umuhengerin isolated from L. trifolia (Rwangabo, 1988) showed 
activity against S. aureus as opposed to the present data where there was no activity against the microbe. 
However, it was not clear from which part of the plant the active compound was isolated. The effects of 
extracts from H. madagascariensis against S. aureus and B. subtilis (Atindehou et al., 2002; Moulari et al., 
2006) and the anti Candida activity of P. barbatus (Runyoro et al., 2006) are confirmed in this work 
Most of the medicinal applications of the secondary metabolites reported in literature are in harmony with 
the traditional medicinal uses of the plants recorded here (Table 6), thus confirming the rationalization for 
the traditional use of the herbal remedies in treating various disease conditions.  
The presence of terpenoids in J. curcas and P. barbatus could be responsible for the medicinal 
properties associated with these plants as they were the major group of compounds expressed on the 
chromatograms after treatment with Anisaldehyde spray reagent (Figure 2). The presence of tannins in P. 
barbatus could also contribute to its medicinal use for treatment of diarrhea as reported by the traditional 
healers. Tannins are glycosides of gallic or protocatechuic acids and have the property of precipitating 
proteins and mucus and also constricting blood vessels. Such stringent action of tannins gives them the 
medicinal value of preventing diarrhea, controlling haemorrhages and treating wounds (Kokwaro, 1993; 
Kisangau, 1999).   
Moreover, the skin healing properties of P. barbatus could be associated with the presence of 
anthraquinones detected in the plant, which could be responsible for the plant’s inhibitory activities against 
S. aureus (Tables 2 and 3). Previous reports indicate that anthraquinones are useful in healing wounds and 
have been used as dressing for burns and other skin lesions (Kokwaro, 1993). They are also a remedy for 
general skin eruptions and have the ability to inhibit the growth of S. aureus, a major cause of many skin 
infections (Mona, 1997). They could also be responsible for its use as purgative, treatment of colics, 
diarrhea, peptic ulcers, typhoid and stomach aches as they have the ability to stimulate bile flow and 
promote activity of the entire digestive process (Mona, 1997). 
Phenolic compounds have been recorded to have diuretic and choleretic effects decreasing the 
viscosity of the blood, reducing blood pressure and stimulating intestinal peristalsis (Farombi, 2003). This 
means that the presence of phenolics in the three traditional plants could be possible candidates for use in 
the management of hypertensive cases. However, it is imperative to note that the healing effects of the 
reported plants could be due to synergistic action of the various compounds found in the plants. For 
example, the traditional use of P.  barbatus for the treatment of diarrhea, colics or as purgative could be an 
effect of the presence of triterpenes, tannins, anthraquinones, flavonols/flavones or chalcones detected in 
the plant extracts (Table 5). 
 
Conclusion 
 
The fact that water extracts portrayed the highest potency of the herbal extracts against the test 
microbes justifies the rationale for use of water as medium for extracting herbal medicines from plants. The 
study unveils rich resources of bioactive plants in Bukoba rural district and lays crucial needs for isolation 
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and development of pharmaceuticals from the extracts reported here. In this study, we are starting efforts to 
incorporate the traditional healers in all stages of our research by signing Material Transfer Agreement 
(MTA) with them. This will ensure that they stand to benefit in the event of pharmaceutical production of 
their knowledge. Any new studies on ethnobotany and ethnomedicine are encouraged to do the same. 
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                      A                                                         B 
Fig 1:  -Activity of Jatropha curcas (JC) against S.  aureus (Sa) (A) and E. coli (Ec) (B).  
           -PB (Plectranthus barbatus), PM (Pseudospondias microcarpa), Am (Ampicillin),   
           Gen (Gentamicin), Wt (water). 
                       
                                A                                                 B 
Figure 2: Test for Terpenoids using Anisaldehyde reagent: (A)-Reference plate (B)-Treated plate. (Solvent 
system: EtOAc: Pet ether/10:90)
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JC
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Wt
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JC
PB
Wt Gen
PM
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Table 2:  Growth inhibition zone means ±SD and AI of plant crude extracts observed in Agar well assays.  
Plant name Part 
extracted 
Extract Conc 
(mg/ml) 
Staphylococcus 
aureus  
Bacillus 
subtilis 
Escherichia 
coli 
Pseudomonas 
aeruginosa 
Candida 
albicans 
Pet 
ether 
150  3.50±0.70 
AI: 0.23 
24.00±1.41 
AI: 1.33 
- - - 
CH2CL2 130  -  9.00±0.00 
AI: 0.5 
  -  - 
Harungana 
madagascariensis 
 
Leaves 
H2O 80 -  -  8.50±0.70 
AI: 0.32 
 -  - 
Pet 
ether 
160 - -  - -  - 
CH2CL2 130  -  10.50±0.70 
AI: 0.58 
 -  -  - 
Jatropha curcas  
 
Leaves 
H2O 85 -  -  -  22.00±0.00 
AI: 0.74 
 - 
Pet 
ether 
25 -  -  8.00±1.41 
AI: 0.31 
 - - 
CH2CL2 40  -  - -  -  - 
Lantana trifolia  
 
Leaves 
H2O 80  -  -  - -  - 
Pet 
ether 
130  7.50±0.70 
AI : 0.5 
 16.50±2.12 
AI : 0.92 
-  - - 
CH2CL2 70  -  -  23.5±2.12 
AI : 0.90 
 - - 
Plectranthus barbatus) Leaves 
H2O 60  33.00±0.00 
AI : 2.4 
 10±2.62 
AI : 0.55 
   - - 
Pet 
ether 
90  -  -  7.5±2.12 
AI: 0.29 
 
-  - 
CH2CL2 160 - - -   8.00±00 
AI: 0.27 
 - 
Pseudospondias 
microcarpa  
Leaves 
H2O 100  -  8.5±0.70 
AI: 0.47 
- -  - 
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Table 2: Growth inhibition zone means ±SD and AI of plant crude extracts observed in Agar well assays ontinued 
Pet 
ether 
100 -  -  8.00±1.41 
AI: 0.31 
- - 
CH2CL2 170 -  7.50±2.12 
AI: 0.42 
 9.00±1.41 
AI: 0.34 
- - 
Psorospermum 
febrifugum  
Bark 
H2O 100 -  9.00±0.00 
AI: 0.50 
 11.00±00 
AI: 0.42 
- - 
Pet 
ether 
170 - 10.00±0.00 
AI: 0.55 
 4.50±0.70 
AI: 0.17 
- - 
CH2CL2 170 - - - - - 
Teclea nobilis  Leaves 
H2O 170 - - - - - 
Leaves Pet 
ether 
70 - -  4.00±0.00 
AI: 0.15 
- - 
 CH2CL2 160 -  6.50±0.70 AI: 0.36 
- - - 
Vernonia adoensis  
 H2O 200 - - - - - 
Standards    Amp: 13.00±1.41 Amp: 11.00±7.07 
Gent: 
20.00±0.00 
Gent: 18.00±2.83 Fluc: 
21.00±0.00 
 
Key: AI: Activity Index = Inhibition zone of the test sample divided by inhibition zone of a standard drug. 
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Table 3:  Growth inhibition zone means ±SD and AI of plant crude extracts observed in Disc diffusion assays.  
Plant name Part 
extracted 
Extract Conc 
(mg/ml) 
Staphylococcus 
aureus  
Bacillus 
subtilis 
Escherichia 
coli 
Pseudomonas 
aeruginosa 
Candida 
albicans 
Pet ether 150 - 8.50±2.12 
AI: 1.06 
- - - 
CH2CL2 130 - 9.50±0.70 
AI: 1.19 
- - - 
Harungana 
madagascariensis 
  
Leaves 
H2O 80 25.00±0.00 
AI: 1.85 
14.00±0.00 
AI: 0.78 
- - - 
Pet ether 160 8.50±0.70 
AI: 0.63 
7.00±0.00 
AI: 0.34 
- 8.50±0.70 
AI: 0.28 
- 
CH2CL2 130 - - 14.5±0.70 
AI: 1.73 
- 9.00±0.00 
AI: 0.32 
Jatropha curcas  
 
Leaves 
H2O 85 40.00±0.00 
AI: 2.96 
8.50±0.70 
AI: 0.47 
39.00±00 
AI: 1.50 
15.00±1.41 
AI: 1.54 
9.00±0.00 
AI: 0.32 
Pet ether 25 - - - - - 
CH2CL2 40 - - - - - 
Lantana trifolia  
 
Leaves 
H2O 80 - - - - - 
Pet ether 130 10.00±1.41 
AI: 0.74 
7.00±0.00 
AI: 0.34 
- 19.00±1.41 
AI: 0.64 
9.00±00 
AI: 0.32 
CH2CL2 70 - - - 21.00±1.41 
AI: 0.71 
6.50±0.70 
AI: 0.23 
Plectranthus 
barbatus  
Leaves 
H2O 60 14.00±1.41 
AI: 1.03 
9.00±2.82 
AI: 0.50 
- - 8.00±0.00 
AI: 0.29 
Pet ether 90 9.00±0.00 
AI: 0.70 
5.50±0.70 
AI: 0.31 
7.50±2.12 
AI: 0.29 
- - 
CH2CL2 160 - - - 6.50±0.70 
AI: 0.22 
- 
Pseudospondias 
microcarpa  
Leaves 
H2O 100 - - - - - 
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Table 3: Growth inhibition zone means ±SD and AI of plant crude extracts observed in Disc diffusion assays coontinued 
Pet ether 100 7.00±1.41 
AI: 0.52 
7.00±1.41 
AI: 0.34 
9.00±00 
AI: 0.35 
- 7.00±00 
AI: 0.25 
CH2CL2 170 - 10.00±0.00 
AI: 0.55 
8.00±0.00 
AI: 0.31 
- - 
Psorospermum 
febrifugum  
Bark 
H2O 100 - - - - - 
Pet ether 170 - - 7.50±0.70 
AI: 0.29 
- - 
CH2CL2 170 - - - - - 
Teclea nobilis  Leaves 
H2O 170 - - - - - 
Vernonia adoensis  Leaves Pet ether 70 - - - - - 
  CH2CL2 160 - - - - - 
  H2O 200 20±0.00 AI: 1.48 
10.00±0.00 
AI: 0.55 
46.00±1.41 
AI: 1.76 
- - 
Standards    Amp: 13..50±1.29 Amp: 18.00±4.24 
Gent: 
26.00±4.61 
Gent: 
29.75.00±2.06 
Fluc: 
27.75±2.62 
Key: AI: Activity Index = Inhibition zone of the test sample divided by inhibition zone of a standard drug. 
- Amp: Ampicillin (10µg/disc), Gent: Gentamicin (15µg/disc), Fluc: Fluconazole 0.4mg/disc). 
 
Table 4: Detection of secondary metabolites by different colour indications 
 
Secondary metabolites Reagent used Positive colour indication 
Alkaloids Dragedorff’s reagent  Orange 
Terpenoids Anisaldehyde  Purple to blue  
Triterpenes 10% Ammonium hydroxide  Purple  
Phenolics  5% Aqueous Iron (III) Chloride  Green to blue  
Tannins  Ferric chloride  Blue-black to green 
Flavonoids Ammonium hydroxide vapour Deep yellow  
Anthraquinones 
 
10% Ammonium hydroxide 
 
Violet 
 
Flavonols/Flavones and/or 
Chalcones  
Aluminium chloride  
 
Yellow 
 
Sterols  50% Acetic anhydride in H2SO4  Green to blue 
 
Saponins Shaking in water Froth formation 
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Table 5:  Distribution of secondary metabolites from the extracts of the selected plant species 
    
Compounds Jatropha curcas  Plectranthus barbatus Pseudospondias microcarpa 
 (Leaves) (Leaves) (Leaves) 
Alkaloids - - - 
Terpenoids + + - 
Triterpenes - + - 
Phenolics + + + 
Tannins + + + 
Flavonoids - + - 
Anthraquinones - + - 
Flavonols/Flavones/    
Chalcones - + - 
Sterols + + + 
Saponins - - - 
 Key: + (Present)        - (Absent)  
              
                          A                                                         B 
Figure 3: Test for Tannins using Ferric chloride: (A)-Reference plate, (B)-Treated plate   
(Solvent system: EtOAc: Pet ether/10:90) 
 
 
 
 
 
                     
 
 
 
 
 
 
 
 
 
 
 
 
                                       A                                                                 B 
Figure 4: Test for Flavones, Flavonols or Chalcones using Aluminium chloride: 
 (A)-Reference plate (B)-Treated plate. (Solvent system: EtOAc: Pet ether/10:90) 
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Table 6: Examples of Secondary metabolites against reported medicinal uses* 
 
Plant name Traditional use Class of compounds Reported medicinal  
uses of the compounds 
Flavonoids a, b, c, d.  
Tannins e, f, d, g. 
Saponins h, i.  
Harungana 
madagascariensis 
Chronic diarrhoea, head ache, malaria, 
dysentery, Jaundice 
Alkaloids j, k.  
Terpenoids l 
Phenolics m, n, o.  
Tannins  e, f, d, g.  
Jatropha curcas Body sores, skin infections, wounds, chest 
diseases, kidney failure. 
Sterols  p, d.  
Lantana trifolia  
 
Chronic cough, rheumatism, indigestion, 
hepatic diseases, colds, flue, anaemia. 
Flavonoids a, b, c, d.  
Terpenoids  l  
Triterpenes  g, q, k.  
Phenolics  m, n, o.  
Tannins  e, f, d, g.  
Flavonoids  a, b, c, d.  
Flavonols/flavones or 
chalcones 
b, k, g.  
Sterols  p, d.  
Plectranthus barbatus 
Oral thrush, skin rashes, ring worms, 
Diarrhoea, Colics, purgative 
Anthraquinones g, d, e.  
Phenolics m, n, o.  
Tannins e, f, d, g. Pseudospondias microcarpa Chronic cough Sterols p, d. 
Psorospermum 
febrifugum Skin infections, pimples, scabies, leprosy 
Phenolics m, n, o. 
Teclea nobilis Weight loss, Chronic cough, rheumatism, fever, pneumonia, anthelmintic, malaria 
Alkaloids j, k. 
Vernonia adoensis TB Terpenoids l 
Key: a-Extend activity of vitamin C, b-Antioxidant, c-Anti-inflammatory, d-Skin injury, wounds, dermal ulcers, 
skin eruptions, dressing burns and skin lesions, e-Prevention of diarrhoea, typhoid, purgative, f-Controlling 
haemorrhages, g-Treating peptic ulcers, abdominal pains, h-Stimulating immune system, i-Arthritis, rheumatism, j-
Bitter tonics, and stomachics, k-Malaria and fever, l-Improvement and maintenance of body health, m-Stimulating 
intestinal peristalsis, n-Diuretic, o-Reducing blood pressure, p-Reducing cholesterol, concentration and maintaining 
good heart health, q-asthma. 
 
*Additional information on traditional uses of the plants and the classes of compounds is from secondary sources: 
Amonkar et al. (1981), Rwangabo (1988), Kokwaro (1993), Beentje (1994), Mona (1997), Kisangau (1999), Craig 
(1999), Okoli et al. (2002), Repetto and Llesuy (2002), Farombi (2003), Wagner and Emadfa (2003), Richelle et al. 
(2004), Berger et al. (2004), Njoroge et al. (2004), Moulari et al. (2006),  
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